The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes

NCT06750783 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

398

Enrollment

OTHER

Sponsor class

Conditions

Prediabetic State (IGT)

Interventions

DRUG: Xuezhikang
DRUG: Atorvastatin

Sponsor

Beijing Tsinghua Chang Gung Hospital